These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2901603)

  • 1. Spaced administration of antibiotic combinations to eliminate pseudomonas from sputum in cystic fibrosis.
    Guggenbichler JP; Allerberger F; Dierich MP; Schmitzberger R; Semenitz E
    Lancet; 1988 Sep; 2(8613):749-50. PubMed ID: 2901603
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacteriological effects of anti-Pseudomonas aeruginosa chemotherapy in cystic fibrosis.
    Bauernfeind A; Emminger G; Hörl G; Ott S; Przyklenk B; Weisslein-Pfister C
    Infection; 1987; 15(5):403-6. PubMed ID: 3121519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic choice for Pseudomonas pulmonary infections in children with cystic fibrosis.
    Bingen E
    Pediatr Pulmonol Suppl; 1997; 16():45. PubMed ID: 9443192
    [No Abstract]   [Full Text] [Related]  

  • 4. Systematic reviews and lifelong diseases.
    Elphick HE; Tan A; Ashby D; Smyth RL
    BMJ; 2002 Aug; 325(7360):381-4. PubMed ID: 12183313
    [No Abstract]   [Full Text] [Related]  

  • 5. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis.
    Hawley HB; Lewis RM; Swartz DR; Gump DW
    Curr Ther Res Clin Exp; 1974 May; 16(5):414-23. PubMed ID: 4209057
    [No Abstract]   [Full Text] [Related]  

  • 6. Minimizing the toxicity of aminoglycosides in cystic fibrosis.
    Smyth AR
    J R Soc Med; 2010 Jul; 103 Suppl 1(Suppl 1):S3-5. PubMed ID: 20573667
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhaled colistin in cystic fibrosis].
    Tamm M; Eich C; Frei R; Gilgen S; Breitenbücher A; Mordasini C
    Schweiz Med Wochenschr; 2000 Sep; 130(39):1366-72. PubMed ID: 11059027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs.
    Elborn JS; Prescott RJ; Stack BH; Goodchild MC; Bates J; Pantin C; Ali N; Shale DJ; Crane M
    Thorax; 2000 May; 55(5):355-8. PubMed ID: 10770814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal.
    Nelson JD
    J Pediatr; 1985 Jun; 106(6):1030-4. PubMed ID: 3889252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment.
    Zabner R; Quinn JP
    Semin Respir Infect; 1992 Sep; 7(3):210-7. PubMed ID: 1475544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti Pseudomonas aeruginosa antibiotic therapy in cystic fibrosis (exclusion of macrolides)].
    Sermet-Gaudelus I; Ferroni A; Vrielinck S; Lebourgeois M; Chedevergne F; Lenoir G
    Arch Pediatr; 2006 Oct; 13 Suppl 1():S30-43. PubMed ID: 17370394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention and drug therapy of penicillin resistant gram-negative rod bacterial infections].
    Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):285-8. PubMed ID: 2185324
    [No Abstract]   [Full Text] [Related]  

  • 13. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobramycin dosing in cystic fibrosis.
    Smyth A; Touw D; Tan KH; Bertenshaw C; Stableforth D
    Lancet; 2005 May 21-27; 365(9473):1767-8. PubMed ID: 15910946
    [No Abstract]   [Full Text] [Related]  

  • 15. Elusiveness of ideal approach to Pseudomonas aeruginosa infection complicating cystic fibrosis.
    Marshall BC; Liou TG
    Lancet; 2000 Aug; 356(9230):613-4. PubMed ID: 10968431
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
    Canis F; Trivier D; Vic P; Ategbo S; Turck D; Husson MO
    Pathol Biol (Paris); 1998 Jun; 46(6):449-51. PubMed ID: 9769880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
    Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
    Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis.
    Smith AL; Fiel SB; Mayer-Hamblett N; Ramsey B; Burns JL
    Chest; 2003 May; 123(5):1495-502. PubMed ID: 12740266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of β-lactams as single agents for treating severe pulmonary exacerbations during pregnancy in cystic fibrosis.
    Prickett M; Jain M
    Am J Respir Crit Care Med; 2012 Dec; 186(12):1310-1. PubMed ID: 23250504
    [No Abstract]   [Full Text] [Related]  

  • 20. Nebulised antipseudomonal therapy in cystic fibrosis.
    Touw DJ; Bakker W
    Thorax; 1996 Dec; 51(12):1283. PubMed ID: 8994535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.